EVAXION BIOTECH A/S (EVAX)
US29970R2040 - ADR
ChartMill assigns a Buy % Consensus number of 80% to EVAX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.88. This target is 235.97% above the current price.
EVAX was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about EVAX.
In the previous month the buy percentage consensus was at a similar level.
EVAX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-02 | Ladenburg Thalmann | Upgrade | Neutral -> Buy |
| 2024-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-12 | HC Wainwright & Co. | Initiate | Buy |
| 2023-12-21 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2023-03-31 | Lake Street | Maintains | Buy |
| 2022-11-17 | Oppenheimer | Maintains | Outperform |
| 2021-03-02 | Oppenheimer | Initiate | Outperform |